Nathan Rich
Stock Analyst at Goldman Sachs
(1.18)
# 3,763
Out of 5,135 analysts
85
Total ratings
36.51%
Success rate
-9.93%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Maintains: Sell | $215 → $158 | $187.12 | -15.56% | 8 | Feb 17, 2026 | |
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $13.70 | +53.28% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $129.13 | +51.79% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $12.49 | +140.19% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $14.85 | -46.13% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $28.50 | -38.60% | 4 | May 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $24.78 | -43.50% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $34.11 | -67.75% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $190.82 | +17.91% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $634.90 | +2.38% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $77.75 | +13.18% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $20.51 | -41.49% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $78.13 | +8.80% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $16.05 | -31.46% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $142.61 | +134.91% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $288.20 | +85.63% | 5 | Dec 14, 2021 |
Humana
Feb 17, 2026
Maintains: Sell
Price Target: $215 → $158
Current: $187.12
Upside: -15.56%
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $13.70
Upside: +53.28%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $129.13
Upside: +51.79%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $12.49
Upside: +140.19%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $14.85
Upside: -46.13%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $28.50
Upside: -38.60%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $24.78
Upside: -43.50%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $34.11
Upside: -67.75%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $190.82
Upside: +17.91%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $634.90
Upside: +2.38%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $77.75
Upside: +13.18%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $20.51
Upside: -41.49%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $78.13
Upside: +8.80%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $16.05
Upside: -31.46%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $142.61
Upside: +134.91%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $288.20
Upside: +85.63%